Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Recruiting · NCT06536868 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-04-24 | NCT06536868 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Hospital of Shanxi Medical University | 23 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Jincheng General Hospital | Jincheng | China | 1 |
| Jinzhong third people's hospital | Jinzhong | China | 1 |
| Second Hospital of Shanxi Medical University | Taiyuan | China | 1 |
| Shanxi Bethune Hospital | Taiyuan | China | 23 |
| Shanxi Hospital of Traditional Chinese Medicine | Taiyuan | China | 1 |
| TISCO General Hospital | Taiyuan | China | 1 |